# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-102919
Filing Date
2024-09-03
Accepted
2024-09-03 17:10:45
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | asnd-20240630.htm iXBRL | 6-K | 1807378
2 | GRAPHIC | img148560552_0.jpg | GRAPHIC | 18727
3 | GRAPHIC | img148560552_1.jpg | GRAPHIC | 105159
4 | GRAPHIC | img148560552_2.jpg | GRAPHIC | 48699
5 | GRAPHIC | img148560552_3.jpg | GRAPHIC | 16184
6 | GRAPHIC | img148560552_4.jpg | GRAPHIC | 18522
7 | GRAPHIC | img148560552_5.jpg | GRAPHIC | 192485
8 | GRAPHIC | img148560552_6.jpg | GRAPHIC | 24875
9 | GRAPHIC | img148560552_7.jpg | GRAPHIC | 19607
| Complete submission text file | 0000950170-24-102919.txt |  | 7489946

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | asnd-20240630.xsd | EX-101.SCH | 1083742
59 | EXTRACTED XBRL INSTANCE DOCUMENT | asnd-20240630_htm.xml | XML | 1091207

Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 241274978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)